Clinical Trial

Interventions for Postoperative Delirium

Study Description

Interventions for Postoperative Delirium: Biomarker-2 (IPOD-B2)

The IPOD-B2 Study aims to understand the pathogenesis of postoperative delirium in patients undergoing major surgery. The investigators will identify then correlate soluble biomarkers in blood and cerebral spinal fluid with changes in High Density-Electroencephalogram.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Procedure - High Density-Electroencephalogram

Additional Information

Official Study Title

Interventions for Postoperative Delirium: Biomarker-2 (IPOD-B2) Pilot Study

Clinical Trial ID

NCT02926417

ParticipAid ID

RdG7Jd